Leclercia adecarboxylata bacteraemia in an immunocompromised patient with metabolic syndrome

Infez Med. 2014 Jun;22(2):149-51.

Abstract

Leclercia adecarboxylata is being increasingly diagnosed as a causative agent of infection due to the availability of rapid molecular diagnostic techniques Few cases of bacteraemia in subjects with underlying medical conditions have been reported. We report a case of L. adecarboxylata bacteraemia in an immunocompromised patient with metabolic syndrome.

Publication types

  • Case Reports

MeSH terms

  • Amoxicillin-Potassium Clavulanate Combination / therapeutic use
  • Bacteremia / diagnosis*
  • Bacteremia / microbiology*
  • Bacteremia / therapy
  • Body Mass Index
  • Debridement / methods
  • Diabetes Mellitus, Type 2 / complications
  • Enterobacteriaceae / isolation & purification*
  • Enterobacteriaceae Infections / complications
  • Enterobacteriaceae Infections / diagnosis*
  • Enterobacteriaceae Infections / therapy
  • Female
  • Humans
  • Hypertension / complications
  • Immunocompromised Host*
  • Leg / pathology
  • Metabolic Syndrome / complications*
  • Middle Aged
  • Risk Factors
  • Treatment Outcome

Substances

  • Amoxicillin-Potassium Clavulanate Combination